The treatment of spasticity with Δ9-tetrahydrocannabinol in persons with spinal cord injury
Authors:
- 17 October 2006
- journal article
- research article
- Published by Springer Nature in Spinal Cord
- Vol. 45 (8) , 551-562
Abstract
Study design: Objectives: Setting: Method: Results: Conclusion:Keywords
This publication has 40 references indexed in Scilit:
- Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trialThe Lancet, 2003
- Pharmacokinetics and Pharmacodynamics of CannabinoidsClinical Pharmacokinetics, 2003
- Motor actions of cannabinoids in the basal ganglia output nucleiLife Sciences, 1999
- The Perceived Effects of Smoked Cannabis on Patients with Multiple SclerosisEuropean Neurology, 1997
- Nabilone in the treatment of multiple sclerosisThe Lancet, 1995
- Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trialEuropean Archives of Psychiatry and Clinical Neuroscience, 1990
- Delta-9-THC in the Treatment of Spasticity Associated with Multiple SclerosisAdvances in Alcohol & Substance Abuse, 1988
- Treatment of Human Spasticity with Δ9‐TetrahydrocannabinolThe Journal of Clinical Pharmacology, 1981
- Marihuana as a therapeutic agent for muscle spasm or spasticityPsychosomatics, 1980
- ON THE THERAPEUTICAL USES AND TOXIC EFFECTS OF CANNABIS INDICA.The Lancet, 1890